Cisatracurium Besylate Injection Recalled Due to Labeling Error
Meitheal Pharmaceuticals is recalling 34,860 vials of Cisatracurium Besylate Injection because cartons were mislabeled as Phenylephrine Hydrochloride.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which is defined as a situation where use of or exposure to a violative product may cause serious adverse health consequences or death. The rubric mandates a score of 5 for FDA Class I recalls.
Plain-English summary
Meitheal Pharmaceuticals Inc. is recalling 34,860 vials of Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05). The product is packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06) and is available by prescription only. The recall is limited to Lot C11507A.
The recall was initiated due to a labeling error where cartons of Cisatracurium Besylate Injection were observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP. The vials were confirmed to contain Cisatracurium Besylate, but the incorrect labeling presents a significant risk of medication error.
The affected product was distributed nationwide in the United States. Healthcare providers and patients should check their inventory for this specific lot number and NDC. If the product is found, it should be discontinued and returned to the manufacturer or a qualified reverse distributor. Patients should not use the product if they have any questions regarding the labeling.
The recalled product
- Product
- CISATRACURIUM BESYLATE (CISATRACURIUM BESYLATE)
- Brand
- CISATRACURIUM BESYLATE
- Manufacturer
- Meitheal Pharmaceuticals Inc
- Category
- Drug — Prescription Injection
- Affected units
- 34,860
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot C11507A
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CISATRACURIUM BESYLATE
- ModerateCisatracurium 200 mg vials recalled after subpotent stability assay results
FDA (Drugs) · 2025-12-24
- ModerateCisatracurium 10 mg vials recalled after subpotent stability assay results
FDA (Drugs) · 2025-12-24
- ModerateCisatracurium 20 mg multiple-dose vials recalled after subpotent assay results
FDA (Drugs) · 2025-12-24
Same manufacturer · Meitheal Pharmaceuticals Inc
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- ModerateGlycopyrrolate Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2021-09-22
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02